Neuronal ceroid lipofuscinosis
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Neuronal ceroid lipofuscinosis | |
|---|---|
| File:Lipofuscin neuro.jpg | |
| Synonyms | Batten disease, CLN disease |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Seizures, vision loss, cognitive decline, motor dysfunction |
| Complications | N/A |
| Onset | Childhood, but can vary depending on the type |
| Duration | Progressive |
| Types | N/A |
| Causes | Genetic mutation |
| Risks | Family history |
| Diagnosis | Genetic testing, MRI, EEG, skin biopsy |
| Differential diagnosis | Other neurodegenerative disorders |
| Prevention | N/A |
| Treatment | Symptomatic management, gene therapy (experimental) |
| Medication | N/A |
| Prognosis | Poor, progressive neurodegeneration |
| Frequency | Rare, varies by type |
| Deaths | N/A |
Neuronal ceroid lipofuscinosis (NCL) is a group of autosomal recessive neurodegenerative disorders, which are collectively classified under the broader category of lysosomal storage disease. The NCLs are characterized by the accumulation of a specific type of lipid-protein complex, known as lipofuscin, within the cells of the body, particularly the neurons.
Etiology[edit]
The NCLs are caused by mutations in various genes, which lead to the production of defective proteins. These proteins are involved in the normal functioning of the lysosome, a cellular organelle responsible for the breakdown and recycling of cellular waste products. The defective proteins result in the accumulation of lipofuscin within the lysosomes, leading to cell death and the clinical manifestations of the disease.
Clinical Features[edit]
The clinical features of the NCLs vary depending on the specific type of NCL, but generally include progressive neurological deterioration, seizures, visual impairment, and motor dysfunction. The onset of symptoms can occur at any age, from infancy to adulthood.
Diagnosis[edit]
The diagnosis of NCL is based on the clinical features, genetic testing, and the presence of characteristic autofluorescent lipofuscin deposits in tissue samples.
Treatment[edit]
There is currently no cure for the NCLs. Treatment is supportive and aimed at managing the symptoms of the disease.
Prognosis[edit]
The prognosis for individuals with NCL is generally poor, with most individuals dying within a few years of diagnosis.
See Also[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
